Found 74 with Last Name = 'shahabi' and Initial = 'd' 
Affinity DataKi: 0.600nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 1.5nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 4.40nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand InfoPDB
3D Structure (crystal)
Affinity DataKi: 5.30nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 8.90nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand InfoPDB
Affinity DataKi: 9.10nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 13nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand InfoPDB
Affinity DataKi: 16nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataKi: 92nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 302nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 388nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 445nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 1.78E+5nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 3.10E+5nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 3.37E+5nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 73nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 250nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 310nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 320nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 340nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 380nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 419nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 470nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 489nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 590nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 870nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 900nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.19E+3nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.22E+3nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 4.43E+3nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+3nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.03E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.53E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
